vs

Side-by-side financial comparison of PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) and UNIVERSAL ELECTRONICS INC (UEIC). Click either name above to swap in a different company.

UNIVERSAL ELECTRONICS INC is the larger business by last-quarter revenue ($87.7M vs $44.6M, roughly 2.0× PACIFIC BIOSCIENCES OF CALIFORNIA, INC.). On growth, PACIFIC BIOSCIENCES OF CALIFORNIA, INC. posted the faster year-over-year revenue change (13.8% vs -20.6%). UNIVERSAL ELECTRONICS INC produced more free cash flow last quarter ($-4.9M vs $-19.9M). Over the past eight quarters, PACIFIC BIOSCIENCES OF CALIFORNIA, INC.'s revenue compounded faster (7.3% CAGR vs -2.3%).

Pacific Biosciences of California, Inc. is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

Universal Electronics Inc. (UEI) is an American smart home technology provider and manufacturer of universal remote controls, IoT devices such as voice-enabled smart home hubs, smart thermostats, home sensors; as well as a white label digital assistant platform optimized for smart home applications, and other software and cloud services for device discovery, fingerprinting and interoperability. The company designs, develops, manufactures and ships products both under the "One For All" brand a...

PACB vs UEIC — Head-to-Head

Bigger by revenue
UEIC
UEIC
2.0× larger
UEIC
$87.7M
$44.6M
PACB
Growing faster (revenue YoY)
PACB
PACB
+34.4% gap
PACB
13.8%
-20.6%
UEIC
More free cash flow
UEIC
UEIC
$15.0M more FCF
UEIC
$-4.9M
$-19.9M
PACB
Faster 2-yr revenue CAGR
PACB
PACB
Annualised
PACB
7.3%
-2.3%
UEIC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
PACB
PACB
UEIC
UEIC
Revenue
$44.6M
$87.7M
Net Profit
$-40.4M
Gross Margin
37.1%
29.7%
Operating Margin
-92.3%
1.0%
Net Margin
-90.4%
Revenue YoY
13.8%
-20.6%
Net Profit YoY
-1802.7%
EPS (diluted)
$-0.11
$-0.09

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PACB
PACB
UEIC
UEIC
Q4 25
$44.6M
$87.7M
Q3 25
$38.4M
$90.6M
Q2 25
$39.8M
$97.7M
Q1 25
$37.2M
$92.3M
Q4 24
$39.2M
$110.5M
Q3 24
$40.0M
$102.1M
Q2 24
$36.0M
$90.5M
Q1 24
$38.8M
$91.9M
Net Profit
PACB
PACB
UEIC
UEIC
Q4 25
$-40.4M
Q3 25
$-38.0M
$-8.3M
Q2 25
$-41.9M
$-2.9M
Q1 25
$-426.1M
$-6.3M
Q4 24
$2.4M
Q3 24
$-60.7M
$-2.7M
Q2 24
$-173.3M
$-8.2M
Q1 24
$-78.2M
$-8.6M
Gross Margin
PACB
PACB
UEIC
UEIC
Q4 25
37.1%
29.7%
Q3 25
41.4%
27.7%
Q2 25
36.9%
29.9%
Q1 25
-3.7%
28.3%
Q4 24
25.6%
28.4%
Q3 24
25.0%
30.1%
Q2 24
16.5%
28.7%
Q1 24
29.1%
28.3%
Operating Margin
PACB
PACB
UEIC
UEIC
Q4 25
-92.3%
1.0%
Q3 25
-101.1%
-5.0%
Q2 25
-112.8%
1.0%
Q1 25
-1154.5%
-4.1%
Q4 24
-390.1%
-3.9%
Q3 24
-160.3%
0.4%
Q2 24
-488.3%
-4.9%
Q1 24
-209.6%
-7.5%
Net Margin
PACB
PACB
UEIC
UEIC
Q4 25
-90.4%
Q3 25
-98.9%
-9.2%
Q2 25
-105.4%
-3.0%
Q1 25
-1146.8%
-6.8%
Q4 24
6.0%
Q3 24
-151.9%
-2.6%
Q2 24
-481.3%
-9.1%
Q1 24
-201.4%
-9.4%
EPS (diluted)
PACB
PACB
UEIC
UEIC
Q4 25
$-0.11
$-0.09
Q3 25
$-0.13
$-0.62
Q2 25
$-0.14
$-0.22
Q1 25
$-1.44
$-0.48
Q4 24
$-0.44
$-0.35
Q3 24
$-0.22
$-0.20
Q2 24
$-0.64
$-0.63
Q1 24
$-0.29
$-0.67

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PACB
PACB
UEIC
UEIC
Cash + ST InvestmentsLiquidity on hand
$279.5M
$32.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$5.3M
$146.2M
Total Assets
$784.1M
$274.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PACB
PACB
UEIC
UEIC
Q4 25
$279.5M
$32.3M
Q3 25
$298.7M
$31.5M
Q2 25
$314.7M
$34.3M
Q1 25
$343.1M
$27.4M
Q4 24
$389.9M
$26.8M
Q3 24
$471.1M
$26.3M
Q2 24
$509.8M
$23.1M
Q1 24
$561.9M
$26.9M
Stockholders' Equity
PACB
PACB
UEIC
UEIC
Q4 25
$5.3M
$146.2M
Q3 25
$36.1M
$146.1M
Q2 25
$61.5M
$152.8M
Q1 25
$91.6M
$150.0M
Q4 24
$506.6M
$153.1M
Q3 24
$453.1M
$161.2M
Q2 24
$492.7M
$159.8M
Q1 24
$649.0M
$169.7M
Total Assets
PACB
PACB
UEIC
UEIC
Q4 25
$784.1M
$274.0M
Q3 25
$803.2M
$280.7M
Q2 25
$825.5M
$304.1M
Q1 25
$860.8M
$310.6M
Q4 24
$1.3B
$323.4M
Q3 24
$1.5B
$321.3M
Q2 24
$1.5B
$314.0M
Q1 24
$1.7B
$322.9M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PACB
PACB
UEIC
UEIC
Operating Cash FlowLast quarter
$-19.1M
$-4.2M
Free Cash FlowOCF − Capex
$-19.9M
$-4.9M
FCF MarginFCF / Revenue
-44.6%
-5.6%
Capex IntensityCapex / Revenue
1.9%
0.8%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-114.1M
$19.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PACB
PACB
UEIC
UEIC
Q4 25
$-19.1M
$-4.2M
Q3 25
$-18.7M
$10.1M
Q2 25
$-29.4M
$8.7M
Q1 25
$-44.1M
$9.0M
Q4 24
$-30.6M
$6.5M
Q3 24
$-45.5M
$5.7M
Q2 24
$-54.3M
$5.5M
Q1 24
$-75.7M
$-2.8M
Free Cash Flow
PACB
PACB
UEIC
UEIC
Q4 25
$-19.9M
$-4.9M
Q3 25
$-18.8M
$9.3M
Q2 25
$-29.9M
$7.5M
Q1 25
$-45.4M
$7.9M
Q4 24
$-32.3M
$5.5M
Q3 24
$-46.3M
$4.8M
Q2 24
$-55.7M
$4.1M
Q1 24
$-79.6M
$-4.1M
FCF Margin
PACB
PACB
UEIC
UEIC
Q4 25
-44.6%
-5.6%
Q3 25
-48.9%
10.2%
Q2 25
-75.3%
7.7%
Q1 25
-122.3%
8.6%
Q4 24
-82.3%
4.9%
Q3 24
-115.7%
4.7%
Q2 24
-154.8%
4.5%
Q1 24
-205.0%
-4.5%
Capex Intensity
PACB
PACB
UEIC
UEIC
Q4 25
1.9%
0.8%
Q3 25
0.2%
1.0%
Q2 25
1.4%
1.2%
Q1 25
3.7%
1.1%
Q4 24
4.1%
0.9%
Q3 24
2.0%
0.8%
Q2 24
4.1%
1.5%
Q1 24
10.0%
1.5%
Cash Conversion
PACB
PACB
UEIC
UEIC
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-12.93×
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PACB
PACB

Products$39.0M87%
Service And Other$5.7M13%

UEIC
UEIC

Other$39.6M45%
Connected Home$29.8M34%
Asia Excluding Peoples Republic Of China$18.4M21%

Related Comparisons